STEPHANIE JOHNSON: Open Payments
NPI 1679025803 · ROUND ROCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$590 in 21 payments from 10 companies in 2025. Trend: 2023 $1,341 · 2024 $560 · 2025 $590
Food & beverage: $590
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 2 | $161 |
| UCB, Inc. | 7 | $152 |
| ANI Pharmaceuticals, Inc. | 3 | $74 |
| ABBVIE INC. | 3 | $55 |
| AstraZeneca Pharmaceuticals LP | 1 | $35 |
| GlaxoSmithKline, LLC. | 1 | $26 |
| PROTEGA PHARMACEUTIALS INC | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| Amgen Inc. | 1 | $23 |
| Aurinia Pharma U.S., Inc. | 1 | $15 |
Products named: PROCLAIM, Bimzelx, PURIFIED CORTROPHIN GEL, RINVOQ, BENLYSTA, ROXYBOND, COSENTYX, OTEZLA.
Industry payments across TX — which companies pay providers there.
